# A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)

> **NCT02121782** · PHASE1,PHASE2 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 84 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Quadrivalent influenza vaccine
- **BIOLOGICAL:** Trivalent influenza vaccine

## Key facts

- **NCT ID:** NCT02121782
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02121782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02121782, "A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02121782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*